News + Filings Holdings
|
|
Affinity Asset Advisors, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
Cerevel Therapeutics Holdings, Inc.
| CERE | Common | 550,000 | 550,000 | 17,484,500,000 | 17,484,500,000 | | |
Hist
| 06/30/2023 |
|
MADRIGAL PHARMACEUTICALS, INC.
| MDGL | CALL | 53,100 | 53,100 | 12,266,100,000 | 12,266,100,000 | | |
Hist
| 06/30/2023 |
|
TEVA PHARMACEUTICAL INDUSTRIES LTD
| TEVA | SPONSORED ADS | 1,600,000 | 1,600,000 | 12,048,000,000 | 12,048,000,000 | | |
Hist
| 06/30/2023 |
|
BIOGEN INC.
| BIIB | Common | 40,000 | 40,000 | 11,394,000,000 | 11,394,000,000 | | |
Hist
| 06/30/2023 |
|
Verona Pharma plc
| VRNA | SPONSORED ADS | 447,667 | 447,667 | 9,463,680,000 | 9,463,680,000 | | |
Hist
| 06/30/2023 |
|
PROTHENA CORP PUBLIC LTD CO
| PRTA | Common | 100,000 | 100,000 | 6,828,000,000 | 6,828,000,000 | | |
Hist
| 06/30/2023 |
|
BridgeBio Pharma, Inc.
| BBIO | Put | 376,000 | 376,000 | 6,467,200,000 | 6,467,200,000 | | |
Hist
| 06/30/2023 |
|
Viking Therapeutics, Inc.
| VKTX | PUT | 350,000 | 350,000 | 5,673,500,000 | 5,673,500,000 | | |
Hist
| 06/30/2023 |
|
Centessa Pharmaceuticals plc
| CNTA | SPONSORED ADS | 900,723 | 900,723 | 5,575,475,000 | 5,575,475,000 | | |
Hist
| 06/30/2023 |
|
Astria Therapeutics, Inc.
| ATXS | Common | 650,875 | 650,875 | 5,421,789,000 | 5,421,789,000 | | |
Hist
| 06/30/2023 |
|
Immunovant, Inc.
| | Common | 260,000 | 260,000 | 4,932,200,000 | 4,932,200,000 | | |
Hist
| 06/30/2023 |
|
Viking Therapeutics, Inc.
| VKTX | COM | 300,000 | 300,000 | 4,863,000,000 | 4,863,000,000 | | |
Hist
| 06/30/2023 |
|
Inozyme Pharma, Inc.
| INZY | Common | 751,796 | 751,796 | 4,187,504,000 | 4,187,504,000 | | |
Hist
| 06/30/2023 |
|
Autolus Therapeutics plc
| AUTL | Common | 1,589,017 | 1,589,017 | 3,781,860,000 | 3,781,860,000 | | |
Hist
| 06/30/2023 |
|
Immatics N.V.
| IMTX | Common | 300,000 | 300,000 | 3,462,000,000 | 3,462,000,000 | | |
Hist
| 06/30/2023 |
|
SpringWorks Therapeutics, Inc.
| SWTX | Common | 130,000 | 130,000 | 3,408,600,000 | 3,408,600,000 | | |
Hist
| 06/30/2023 |
|
Ventyx Biosciences, Inc.
| VTYX | Common | 100,696 | 100,696 | 3,302,829,000 | 3,302,829,000 | | |
Hist
| 06/30/2023 |
|
Viridian Therapeutics, Inc.\DE
| VRDN | Call | 130,400 | 130,400 | 3,102,216,000 | 3,102,216,000 | | |
Hist
| 06/30/2023 |
|
REATA PHARMACEUTICALS INC
| RETA | Common | 29,105 | 29,105 | 2,967,546,000 | 2,967,546,000 | | |
Hist
| 06/30/2023 |
|
FIBROGEN INC
| FGEN | COM | 983,300 | 983,300 | 2,654,910,000 | 2,654,910,000 | | |
Hist
| 06/30/2023 |
|
FIBROGEN INC
| FGEN | PUT | 983,300 | 983,300 | 2,654,910,000 | 2,654,910,000 | | |
Hist
| 06/30/2023 |
|
Xenon Pharmaceuticals Inc.
| XENE | COM | 60,376 | 60,376 | 2,324,476,000 | 2,324,476,000 | | |
Hist
| 06/30/2023 |
|
Theseus Pharmaceuticals, Inc.
| THRX | Common | 240,244 | 240,244 | 2,241,477,000 | 2,241,477,000 | | |
Hist
| 06/30/2023 |
|
Aeglea BioTherapeutics, Inc.
| AGLE | COM | 4,900,000 | 4,900,000 | 2,207,450,000 | 2,207,450,000 | | |
Hist
| 06/30/2023 |
|
Cabaletta Bio, Inc.
| CABA | Common | 125,000 | 125,000 | 1,613,750,000 | 1,613,750,000 | | |
Hist
| 06/30/2023 |
|
KalVista Pharmaceuticals, Inc.
| KALV | Common | 178,292 | 178,292 | 1,604,628,000 | 1,604,628,000 | | |
Hist
| 06/30/2023 |
|
ADC Therapeutics SA
| | Common | 600,000 | 600,000 | 1,290,000,000 | 1,290,000,000 | | |
Hist
| 06/30/2023 |
|
Aadi Bioscience, Inc.
| AADI | Common | 187,675 | 187,675 | 1,283,697,000 | 1,283,697,000 | | |
Hist
| 06/30/2023 |
|
Aldeyra Therapeutics, Inc.
| ALDX | COM | 150,000 | 150,000 | 1,258,500,000 | 1,258,500,000 | | |
Hist
| 06/30/2023 |
|
ALPINE IMMUNE SCIENCES, INC.
| ALPN | Common | 118,891 | 118,891 | 1,222,199,000 | 1,222,199,000 | | |
Hist
| 06/30/2023 |
|
NewAmsterdam Pharma Co N.V.
| NAMS | Common | 100,000 | 100,000 | 1,189,000,000 | 1,189,000,000 | | |
Hist
| 06/30/2023 |
|
Aravive, Inc.
| ARAV | PUT | 861,200 | 861,200 | 1,085,112,000 | 1,085,112,000 | | |
Hist
| 06/30/2023 |
|
InflaRx N.V.
| IFRX | Common | 240,200 | 240,200 | 1,071,292,000 | 1,071,292,000 | | |
Hist
| 06/30/2023 |
|
Mineralys Therapeutics, Inc.
| MLYS | Common | 62,500 | 62,500 | 1,065,625,000 | 1,065,625,000 | | |
Hist
| 06/30/2023 |
|
Nurix Therapeutics, Inc.
| NRIX | Common | 100,000 | 100,000 | 999,000,000 | 999,000,000 | | |
Hist
| 06/30/2023 |
| << Prev Next >> |
|
|
|
|